Speakers

Expand/Collapse

Vasily Fedorin
Director of Operations
4BIO Capital

Marcus Rauch
Co-Founder & CSO
AlphaBiomics

Day Two

Friday, 29th January 2021

5:00 pm | Leveraging the Microbiome to Deliver Safer and More Efficacious Drug Therapies

Mark Bamforth
President & CEO
Arranta Bio

Day Two

Friday, 29th January 2021

10:30 am | Meeting the Supply Needs of the Microbiome Sector

Prof Ted Dinan
Medical Director
Atlantia Food Clinical

Elran Haber
CEO
Biomica

Day One

Thursday, 28th January 2021

9:00 am | European Microbiome Leaders Panel Discussion

Shiri Meshner
VP R&D
Biomica

Assaf Oron
Chief Business Officer
BiomX

Day Two

Friday, 29th January 2021

5:30 pm | A Novel Machine Learning Approach to Microbiome Based Biomarker Discovery

Adrien Nivoliez
CEO
biose industrie

Kristofer Cook
CEO & Co-Founder
Carbiotix

Arne Materna
VP Product
Cosmos ID

Day One

Thursday, 28th January 2021

10:30 am | Shotgun Sequencing & Strain-Level Analysis: Study Design for Pre-Clinical & Clinical Development

Matthew Cummings
CEO & Co-Founder
CCBio

Day One

Thursday, 28th January 2021

5:00 pm | Collaboration Roundtable Discussions

Sebastien Guery
Technology & Innovation Leader
DuPont Nutrition & Biosciences

Xavier Duportet
CEO
Eligo Biosciences

Gregoire Chevalier
Scientific Affairs Manager
Enterome

Benjamin Hadida
CEO & Co-Founder
Exeliom Biosciences

Day One

Thursday, 28th January 2021

9:00 am | European Microbiome Leaders Panel Discussion

Mathilde Antoine
Operations Manager
Exeliom Biosciences

Alexandre Almeida
EBI-Sanger Postdoctoral Fellowship
European Bioinformatics Institute

Rob Finn
Head of Microbiome Informatics Team
European Bioinformatics Institute

Day One

Thursday, 28th January 2021

4:30 pm | Magnifying the Human Gut Microbiome

Dirk Hadrich
Policy and Programme Officer
European Commission

Jenny Bailey
CEO & Co-Founder
Ferryx

Dr Jenny Bailey is Co-founder and CEO of Ferryx Ltd and is responsible for developing and delivering the company strategy. She has a PhD in gastrointestinal immunology and 16 years’ research experience in gastrointestinal disease in humans and animals.

Day One

Thursday, 28th January 2021

5:00 pm | Collaboration Roundtable Discussions

Paul Carlson
Principal Investigator
CBER

Day Two

Friday, 29th January 2021

9:30 am | Regulatory and Clinical Considerations for LBPs

Zain Kassam
CMO
Finch Therapeutics

Sam Minot
Staff Scientist
Fred Hutchinson Cancer Research Center

Craig Thompson
Partner
HGF Limited

Pamela Pruski
Research Associate
Imperial College London

Day One

Thursday, 28th January 2021

5:00 pm | Collaboration Roundtable Discussions

Georges Rawadi
CEO
LNC Therapeutics

Day One

Thursday, 28th January 2021

9:00 am | European Microbiome Leaders Panel Discussion

Tina Christensen-Ram
General Manager Quality
Luina Bio

Hervé Affagard
Founder and CEO
MaaT Pharma

Lutz Kraus
Head of Data-Mining and Artificial Intelligence
Microba

Mike Romanos
CEO
Microbiotica

Day One

Thursday, 28th January 2021

9:00 am | European Microbiome Leaders Panel Discussion

Day Two

Friday, 29th January 2021

4:30 pm | Rational Design of Gut Microbiome Biomarkers and LBTs to Optimize Cancer Immunotherapy curation

Trevor Lawley
CSO
Microbiotica

Mat Robinson
VP
Translational Biology

Day One

Thursday, 28th January 2021

5:00 pm | Collaboration Roundtable Discussions

Sam Possemiers
CEO
MRM Health

Day One

Thursday, 28th January 2021

5:00 pm | Collaboration Roundtable Discussions

Fabio Grassi
Founder
MVBiotherapeutics

Conrad Lichtenstein
CSO
Nemesis Bioscience

Stanislas Desjonqueres
CEO
Nexbiome Therapeutics

Mark Fitzgerald
Partner
Nixon Peabody LLP

Gregory Amos
Head of Microbiome Section
NIBSC

Day Two

Friday, 29th January 2021

10:00 am | Developing Standards for the Microbiome Field

Alice Rounet
Regulatory Affairs Associate
Pharmabiotic Rese

Day Two

Friday, 29th January 2021

9:00 am | Development of Microbiome-Based Medicinal Products in Europe: Regulatory Considerations

Aurelien Baudot
Head of Business Development
ProDigest

Ken Blount
CSO
Rebiotix

Eric van der Helm
Head of Synthetic Biology & Bioinformatic
SNIPR Biome

Tomas de Wouters
CEO & Co-Founder
PharmaBiome

Todd DeSantis
Co-Founder and VP Informatics
Second Genome

Day Two

Friday, 29th January 2021

4:00 pm | Discovery of Pharmacological Agents Emitted by Intestinal Bacteria

Matt Henn
CSO
Seres Therapeutics

Nicole McKnight
CEO
Stellate Therapeutics

Day One

Thursday, 28th January 2021

5:00 pm | Collaboration Roundtable Discussions

Nikhil Sharma
MD Consultant Neurologist and Senior Clinical Researcher
UCL

Day One

Thursday, 28th January 2021

5:00 pm | Collaboration Roundtable Discussions

Prof Sahar El Aidy
Department of Molecular Immunology & Microbiology
University of Groningen

Day One

Thursday, 28th January 2021

5:00 pm | Collaboration Roundtable Discussions

Dr. Imke Mulder
Research Director,
4D Pharma

Kathleen Brennan
Director Microbiology
Boston Analytical

Day One

Thursday, 28th January 2021

10:00 am | Gut Microbiome Endgame: Ramping up cGMP Program Design to Ensure Regulatory Preparedness for Microbiome Products

Alex Stevenson
CSO
4D Pharma

Day One

Thursday, 28th January 2021

9:00 am | European Microbiome Leaders Panel Discussion